Skip to content

Latest News & Analysis Page 781

Latest News

News

NantKwest Stock Surges 42% On News Of ImmunityBio Merger

Shares of cell-based therapeutics company NantKwest (NASDAQ: NK) are surging on Monday after the announcement of a merger with privately-held immunotherapy firm, ImmunityBio. The deal is a stock-for-stock…

Stay ahead of the markets

Sign up to our free Morning Markets email, every weekday before the open.